Cipla Ltd.

BSE: 500087 | NSE: CIPLA
Large Cap | Pharmaceuticals & Drugs
1383.00
6.75 (0.49%)
< Home < Back

Cipla’s arm incorporates new wholly owned subsidiary in Germany

Date: 30-05-2025

Cipla’s wholly owned subsidiary -- Cipla (EU), UK has incorporated a new wholly owned subsidiary named ‘CiplaRna GmbH’ in Germany, effective May 28, 2025. CiplaRna has been incorporated with the objective of establishing a laboratory for mRNA-based formulation and drug development support.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.